1V4T - JenaLib

Asymmetric/Biological Unit (63, 63)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_010584	R	36	W	HXK4_HUMAN	Disease (MODY2)	762263694	A	R	36	W
02	UniProt	VAR_075220	R	43	H	HXK4_HUMAN	Unclassified (MODY2)	764232985	A	R	43	H
03	UniProt	VAR_010585	A	53	S	HXK4_HUMAN	Disease (MODY2)	---	A	A	53	S
04	UniProt	VAR_078243	T	65	I	HXK4_HUMAN	Disease (HHF3)	---	A	T	65	I
05	UniProt	VAR_075221	G	68	D	HXK4_HUMAN	Unclassified (MODY2)	373418736	A	G	68	D
06	UniProt	VAR_003693	E	70	K	HXK4_HUMAN	Disease (MODY2)	---	A	E	70	K
07	UniProt	VAR_003694	G	80	A	HXK4_HUMAN	Disease (MODY2)	---	A	G	80	A
08	UniProt	VAR_003695	G	80	S	HXK4_HUMAN	Disease (MODY2)	---	A	G	80	S
09	UniProt	VAR_078244	V	91	L	HXK4_HUMAN	Disease (HHF3)	---	A	V	91	L
10	UniProt	VAR_078245	W	99	C	HXK4_HUMAN	Disease (HHF3)	---	A	W	99	C
11	UniProt	VAR_003696	M	107	T	HXK4_HUMAN	Polymorphism	---	A	M	107	T
12	UniProt	VAR_010586	Y	108	H	HXK4_HUMAN	Disease (MODY2)	---	A	Y	108	H
13	UniProt	VAR_012352	I	110	T	HXK4_HUMAN	Disease (MODY2)	---	A	I	110	T
14	UniProt	VAR_012353	A	119	D	HXK4_HUMAN	Disease (MODY2)	---	A	A	119	D
15	UniProt	VAR_078246	C	129	Y	HXK4_HUMAN	Disease (MODY2)	---	A	C	129	Y
16	UniProt	VAR_003697	S	131	P	HXK4_HUMAN	Disease (MODY2)	104894010	A	S	131	P
17	UniProt	VAR_010587	H	137	R	HXK4_HUMAN	Disease (MODY2)	---	A	H	137	R
18	UniProt	VAR_010588	F	150	S	HXK4_HUMAN	Disease (MODY2)	193922297	A	F	150	S
19	UniProt	VAR_078247	F	152	L	HXK4_HUMAN	Unclassified (MODY2)	---	A	F	152	L
20	UniProt	VAR_003699	V	182	M	HXK4_HUMAN	Disease (MODY2)	587780345	A	V	182	M
21	UniProt	VAR_003700	A	188	T	HXK4_HUMAN	Disease (MODY2)	751279776	A	A	188	T
22	UniProt	VAR_078248	A	188	V	HXK4_HUMAN	Disease (MODY2)	193922307	A	A	188	V
23	UniProt	VAR_078249	R	191	W	HXK4_HUMAN	Disease (MODY2)	---	A	R	191	W
24	UniProt	VAR_078250	M	202	R	HXK4_HUMAN	Unclassified (MODY2)	---	A	M	202	R
25	UniProt	VAR_003701	V	203	A	HXK4_HUMAN	Disease (MODY2)	---	A	V	203	A
26	UniProt	VAR_010590	T	209	M	HXK4_HUMAN	Disease (MODY2)	---	A	T	209	M
27	UniProt	VAR_012351	M	210	K	HXK4_HUMAN	Disease (MODY2)	80356654	A	M	210	K
28	UniProt	VAR_010591	M	210	T	HXK4_HUMAN	Disease (MODY2)	---	A	M	210	T
29	UniProt	VAR_010592	C	213	R	HXK4_HUMAN	Disease (MODY2)	---	A	C	213	R
30	UniProt	VAR_075222	D	217	N	HXK4_HUMAN	Disease (MODY2)	147065275	A	D	217	N
31	UniProt	VAR_003702	E	221	K	HXK4_HUMAN	Disease (MODY2)	193922317	A	E	221	K
32	UniProt	VAR_078251	G	223	S	HXK4_HUMAN	Disease (MODY2)	---	A	G	223	S
33	UniProt	VAR_075223	I	225	M	HXK4_HUMAN	Disease (MODY2)	---	A	I	225	M
34	UniProt	VAR_003703	V	226	M	HXK4_HUMAN	Disease (MODY2)	148311934	A	V	226	M
35	UniProt	VAR_003704	G	227	C	HXK4_HUMAN	Disease (MODY2)	---	A	G	227	C
36	UniProt	VAR_003705	T	228	M	HXK4_HUMAN	Disease (MODY2)	80356655	A	T	228	M
37	UniProt	VAR_078252	N	231	H	HXK4_HUMAN	Unclassified (MODY2)	---	A	N	231	H
38	UniProt	VAR_075224	E	248	K	HXK4_HUMAN	Disease (MODY2)	759421263	A	E	248	K
39	UniProt	VAR_003706	E	256	K	HXK4_HUMAN	Disease (MODY2)	769268803	A	E	256	K
40	UniProt	VAR_003707	W	257	R	HXK4_HUMAN	Disease (MODY2)	---	A	W	257	R
41	UniProt	VAR_010593	A	259	T	HXK4_HUMAN	Disease (MODY2)	---	A	A	259	T
42	UniProt	VAR_010594	G	261	E	HXK4_HUMAN	Disease (MODY2)	---	A	G	261	E
43	UniProt	VAR_003708	G	261	R	HXK4_HUMAN	Disease (MODY2)	104894008	A	G	261	R
44	UniProt	VAR_003709	E	279	Q	HXK4_HUMAN	Disease (MODY2)	104894005	A	E	279	Q
45	UniProt	VAR_003710	G	299	R	HXK4_HUMAN	Disease (MODY2)	104894009	A	G	299	R
46	UniProt	VAR_003712	E	300	K	HXK4_HUMAN	Disease (MODY2)	---	A	E	300	K
47	UniProt	VAR_003711	E	300	Q	HXK4_HUMAN	Disease (MODY2)	---	A	E	300	Q
48	UniProt	VAR_003713	L	309	P	HXK4_HUMAN	Disease (MODY2)	---	A	L	309	P
49	UniProt	VAR_078253	L	315	F	HXK4_HUMAN	Unclassified (MODY2)	---	A	L	315	F
50	UniProt	VAR_010595	S	336	L	HXK4_HUMAN	Disease (MODY2)	---	A	S	336	L
51	UniProt	VAR_066615	T	342	P	HXK4_HUMAN	Polymorphism	---	A	T	342	P
52	UniProt	VAR_010596	V	367	M	HXK4_HUMAN	Disease (MODY2)	---	A	V	367	M
53	UniProt	VAR_078254	A	378	T	HXK4_HUMAN	Disease (MODY2)	104894016	A	A	378	T
54	UniProt	VAR_010597	C	382	Y	HXK4_HUMAN	Disease (MODY2)	---	A	C	382	Y
55	UniProt	VAR_010598	A	384	T	HXK4_HUMAN	Disease (MODY2)	---	A	A	384	T
56	UniProt	VAR_012354	G	385	V	HXK4_HUMAN	Disease (MODY2)	---	A	G	385	V
57	UniProt	VAR_010599	R	392	C	HXK4_HUMAN	Disease (MODY2)	---	A	R	392	C
58	UniProt	VAR_003714	K	414	E	HXK4_HUMAN	Disease (MODY2)	193922272	A	K	414	E
59	UniProt	VAR_078255	C	434	F	HXK4_HUMAN	Unclassified (MODY2)	---	A	C	434	F
60	UniProt	VAR_078256	S	441	W	HXK4_HUMAN	Disease (MODY2)	---	A	S	441	W
61	UniProt	VAR_078257	E	442	K	HXK4_HUMAN	Disease (HHF3)	758737171	A	E	442	K
62	UniProt	VAR_078258	R	447	Q	HXK4_HUMAN	Disease (MODY2)	---	A	R	447	Q
63	UniProt	VAR_003715	V	455	M	HXK4_HUMAN	Disease (HHF3)	104894012	A	V	455	M

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

PROSITE Motifs (1, 1)

Exons (0, 0)

Sequences/Alignments

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:424
 aligned with HXK4_HUMAN | P35557 from UniProtKB/Swiss-Prot  Length:465

    Alignment length:447
                                    24        34        44        54        64        74        84        94       104       114       124       134       144       154       164       174       184       194       204       214       224       234       244       254       264       274       284       294       304       314       324       334       344       354       364       374       384       394       404       414       424       434       444       454       
           HXK4_HUMAN    15 KVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKAC 461
               SCOP domains d1v4ta1 A:15-218 Glucokinase                                                                                                                                                                                d1v4ta2 A:219-461 Glucokinase                                                                                                                                                                                                                       SCOP domains
               CATH domains 1v4tA01 A:15-59,A:218-444                    --------------------------------------------------------------------------------------------------------------------------------------------------------------1v4tA01 A:15-59,A:218-444  [code=3.40.367.20, no name defined]                                                                                                                                                                     ----------------- CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .hhhhhhh...hhhhhhhhhhhhhhhhhhhhh...........ee..............eeeeeee..eeeeeeeeee.......eeeeeeeeee.hhhhhh.hhhhhhhhhhhhhhhhhhhh......eeeeee.......-----------------------hhhhhhhhhhhhh......eee..hhhhhhhhhhhhhh..eeeeeee...eeeeeeee.hhh........eeeee.hhhhh..........hhhhhhhhh.........hhhhhh..hhhhhhhhhhhhhhhh..................hhhhhhhhhh....hhhhhhhhhh.....hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh....eeeeeeeehhhhhhhhhhhhhhhhhhhh....eeeeeee......hhhhhhhhhhhhhh. Sec.struct. author
             SAPs(SNPs) (1) ---------------------W------H---------S-----------I--D-K---------A----------L-------C-------TH-T--------D---------Y-P-----R------------S-L-----------------------------M-----T--W----------RA-----MK--R---N---K-S-MMCM--H----------------K-------KR-T-E-----------------Q-------------------RK--------P-----F--------------------L-----P------------------------M----------T---Y-TV------C---------------------E-------------------F------WK----Q-------M------ SAPs(SNPs) (1)
             SAPs(SNPs) (2) -----------------------------------------------------------------S-----------------------------------------------------------------------------------------------------------V---------------------T--------------------------------------------------R--------------------------------------Q----------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (2)
                    PROSITE -----------------------------------------------------------------------------------------------------------------------------------HEXOKINASE_1              -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
                 Transcript --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript
                 1v4t A  15 MVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRH-----------------------NVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKAC 461
                                    24        34        44        54        64        74        84        94       104       114       124       134       144       154 |       -         -     | 184       194       204       214       224       234       244       254       264       274       284       294       304       314       324       334       344       354       364       374       384       394       404       414       424       434       444       454       
                                                                                                                                                                       156                     180

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (1, 2)

CATH Domains (1, 1)

Pfam Domains (0, 0)

Gene Ontology (57, 57)

Asymmetric/Biological Unit(hide GO term definitions)

Chain A (HXK4_HUMAN | P35557)

molecular function
	GO:0043531	ADP binding	Interacting selectively and non-covalently with ADP, adenosine 5'-diphosphate.
	GO:0005524	ATP binding	Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
	GO:0003824	catalytic activity	Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.
	GO:0008865	fructokinase activity	Catalysis of the reaction: ATP + D-fructose = ADP + D-fructose 6-phosphate.
	GO:0004340	glucokinase activity	Catalysis of the reaction: ATP + D-glucose = ADP + D-glucose-6-phosphate.
	GO:0005536	glucose binding	Interacting selectively and non-covalently with the D- or L-enantiomer of glucose.
	GO:0004396	hexokinase activity	Catalysis of the reaction: ATP + D-hexose = ADP + D-hexose 6-phosphate.
	GO:0016301	kinase activity	Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
	GO:0000287	magnesium ion binding	Interacting selectively and non-covalently with magnesium (Mg) ions.
	GO:0019158	mannokinase activity	Catalysis of the reaction: ATP + D-mannose = ADP + D-mannose 6-phosphate.
	GO:0000166	nucleotide binding	Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
	GO:0016773	phosphotransferase activity, alcohol group as acceptor	Catalysis of the transfer of a phosphorus-containing group from one compound (donor) to an alcohol group (acceptor).
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0019903	protein phosphatase binding	Interacting selectively and non-covalently with any protein phosphatase.
	GO:0016740	transferase activity	Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
biological process
	GO:0006739	NADP metabolic process	The chemical reactions and pathways involving nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; metabolism may be of either the oxidized form, NADP, or the reduced form, NADPH.
	GO:0070509	calcium ion import	The directed movement of calcium ions into a cell or organelle.
	GO:0061621	canonical glycolysis	The glycolytic process that begins with the conversion of glucose to glucose-6-phosphate by glucokinase activity. Glycolytic processes are the chemical reactions and pathways resulting in the breakdown of a carbohydrate into pyruvate, with the concomitant production of a small amount of ATP.
	GO:0005975	carbohydrate metabolic process	The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y. Includes the formation of carbohydrate derivatives by the addition of a carbohydrate residue to another molecule.
	GO:0046835	carbohydrate phosphorylation	The process of introducing a phosphate group into a carbohydrate, any organic compound based on the general formula Cx(H2O)y.
	GO:0001678	cellular glucose homeostasis	A cellular homeostatic process involved in the maintenance of an internal steady state of glucose within a cell or between a cell and its external environment.
	GO:0042149	cellular response to glucose starvation	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of glucose.
	GO:0032869	cellular response to insulin stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
	GO:0044320	cellular response to leptin stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leptin stimulus. Leptin is a hormone manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body. It plays a key role in regulating energy intake and energy expenditure, including appetite and metabolism.
	GO:0051594	detection of glucose	The series of events in which a glucose stimulus is received by a cell and converted into a molecular signal.
	GO:0006003	fructose 2,6-bisphosphate metabolic process	The chemical reactions and pathways involving fructose 2,6-bisphosphate. The D enantiomer is an important regulator of the glycolytic and gluconeogenic pathways. It inhibits fructose 1,6-bisphosphatase and activates phosphofructokinase.
	GO:0051156	glucose 6-phosphate metabolic process	The chemical reactions and pathways involving glucose 6-phosphate, a monophosphorylated derivative of glucose with the phosphate group attached to C-6.
	GO:0042593	glucose homeostasis	Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.
	GO:0006006	glucose metabolic process	The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides.
	GO:0015758	glucose transport	The directed movement of the hexose monosaccharide glucose into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
	GO:0005978	glycogen biosynthetic process	The chemical reactions and pathways resulting in the formation of glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues.
	GO:0006096	glycolytic process	The chemical reactions and pathways resulting in the breakdown of a carbohydrate into pyruvate, with the concomitant production of a small amount of ATP and the reduction of NAD(P) to NAD(P)H. Glycolysis begins with the metabolism of a carbohydrate to generate products that can enter the pathway and ends with the production of pyruvate. Pyruvate may be converted to acetyl-coenzyme A, ethanol, lactate, or other small molecules.
	GO:0055088	lipid homeostasis	Any process involved in the maintenance of an internal steady state of lipid within an organism or cell.
	GO:0008152	metabolic process	The chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation.
	GO:0032811	negative regulation of epinephrine secretion	Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of epinephrine.
	GO:0045721	negative regulation of gluconeogenesis	Any process that stops, prevents, or reduces the frequency, rate or extent of gluconeogenesis.
	GO:0016310	phosphorylation	The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
	GO:0007204	positive regulation of cytosolic calcium ion concentration	Any process that increases the concentration of calcium ions in the cytosol.
	GO:0045725	positive regulation of glycogen biosynthetic process	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen.
	GO:0045821	positive regulation of glycolytic process	Any process that activates or increases the frequency, rate or extent of glycolysis.
	GO:0032024	positive regulation of insulin secretion	Any process that activates or increases the frequency, rate or extent of the regulated release of insulin.
	GO:0042327	positive regulation of phosphorylation	Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to a molecule.
	GO:0010827	regulation of glucose transport	Any process that modulates the frequency, rate or extent of glucose transport. Glucose transport is the directed movement of the hexose monosaccharide glucose into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
	GO:0006110	regulation of glycolytic process	Any process that modulates the frequency, rate or extent of glycolysis.
	GO:0050796	regulation of insulin secretion	Any process that modulates the frequency, rate or extent of the regulated release of insulin.
	GO:0043266	regulation of potassium ion transport	Any process that modulates the frequency, rate or extent of the directed movement of potassium ions (K+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
	GO:0009749	response to glucose	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
	GO:0019932	second-messenger-mediated signaling	Any intracellular signal transduction in which the signal is passed on within the cell via a second messenger; a small molecule or ion that can be quickly generated or released from intracellular stores, and can diffuse within the cell. Second-messenger signaling includes production or release of the second messenger, and effectors downstream of the second messenger that further transmit the signal within the cell.
cellular component
	GO:0005884	actin filament	A filamentous structure formed of a two-stranded helical polymer of the protein actin and associated proteins. Actin filaments are a major component of the contractile apparatus of skeletal muscle and the microfilaments of the cytoskeleton of eukaryotic cells. The filaments, comprising polymerized globular actin molecules, appear as flexible structures with a diameter of 5-9 nm. They are organized into a variety of linear bundles, two-dimensional networks, and three dimensional gels. In the cytoskeleton they are most highly concentrated in the cortex of the cell just beneath the plasma membrane.
	GO:0045180	basal cortex	The region that lies just beneath the plasma membrane on the basal edge of a cell.
	GO:0005938	cell cortex	The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins.
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0005739	mitochondrion	A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
	GO:0005654	nucleoplasm	That part of the nuclear content other than the chromosomes or the nucleolus.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
	GO:0030141	secretory granule	A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (2, 3)

Sites (3, 3)

SS Bonds (0, 0)

Cis Peptide Bonds (0, 0)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (63, 63)

PROSITE Motifs (1, 1)

Exons (0, 0)

Sequences/Alignments

Classification and Annotation

SCOP Domains (1, 2)

CATH Domains (1, 1)

Pfam Domains (0, 0)

Gene Ontology (57, 57)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File